Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;66(4):775-82.
doi: 10.1002/art.38323.

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Daniel H Solomon  1 , Asaf Bitton, Jeffrey N Katz, Helga Radner, Erika M Brown, Liana Fraenkel
Affiliations
Review

Review: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?

Daniel H Solomon et al. Arthritis Rheumatol. 2014 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts: Dr. Solomon receives salary support from research support to Brigham and Women’s Hospital from Amgen, Lilly, and CORRONA. He serves in unpaid roles on trials funding by Pfizer, Novartis, Lilly and Bristol Myers Squibb. He receives royalties from UpToDate.

Figures

Figure 1
Figure 1
Research Agenda for Treat to Target in Rheumatoid Arthritis * These questions might be considered “patient-centered.”
See this image and copyright information in PMC

References

    1. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364(9430):263–9. - PubMed
    1. Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) Ann Rheum Dis. 2007;66(11):1443–9. - PMC - PubMed
    1. Fransen J, Moens HB, Speyer I, van Riel PL. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis. 2005;64(9):1294–8. - PMC - PubMed
    1. Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46(4):894–8. - PubMed
    1. Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, et al. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum. 2008;58(5):1310–7. - PubMed

Publication types

MeSH terms

Substances